Merck & Company Inc (MRK)

91.50
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    91.50 - 91.50
  • Type:Equity
  • Market:Peru
  • ISIN:US58933Y1055
  • S/N:MRK

MRK Overview

Prev. Close
92.1
Day's Range
91.5-91.5
Revenue
-
Open
91.5
52 wk Range
73.2-92.1
EPS
-
Volume
0
Market Cap
236.57B
Dividend (Yield)
2.76
(3.02%)
Average Vol. (3m)
574
P/E Ratio
-
Beta
-
1-Year Change
26.26%
Shares Outstanding
2,528,805,025
Next Earnings Date
Jul 28, 2022
What is your sentiment on Merck&Co?
or
Market is currently closed. Voting is open during market hours.

Merck & Company Inc News

Merck & Company Inc Analysis

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyBuyBuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • This will be 120+ soon
    1
    • ma e' sui massimi da sempre? che t.p. si puo' immaginare a questo punto ?
      0
      • 🚀🚀🚀🚀🚀🚀🚀🌜
        0
        • Good, even great reasults in first quater of 2022.Let's hope to go back to 86-87 territory
          0
          • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention.
            0
            • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
              0
              • The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
                0
                • It was 22 in 1995. Do the math and look at the products.
                  0
                  • Hope can break 80 this week
                    0
                    • It should reach 120 soon
                      0